Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19
Sponsor: Institut de Recherches Internationales Servier
Summary
The purpose of this study is to evaluate the long-term safety and efficacy of UCART19 administration to patients with advanced lymphoid leukemia.
Official title: Long-term Follow-up Study of Patients Who Have Previously Been Exposed to UCART19 (Allogeneic Engineered T-cells Expressing a Lentiviral-based Anti-CD19 Chimeric Antigen Receptor)
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2021-03-10
Completion Date
2028-09
Last Updated
2025-04-11
Healthy Volunteers
No
Conditions
Interventions
UCART19 follow-up
UCART19 will not be administered during the study period. Patients who will be rolled-over from the parent study to this long term follow-up study, have previously received UCART19. The roll-over occurs at the end of the parent study, or at any time after UCART19 administration, in case of premature discontinuation from the parent study.
Locations (16)
Children's Hospital Los Angeles
Los Angeles, California, United States
Colorado Blood Cancer Institute
Denver, Colorado, United States
Moffit Cancer Center
Tampa, Florida, United States
Massachussetts General Hospital
Charlestown, Massachusetts, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Hôpital Saint-Louis
Paris, France
Hôpital Robert-Debré
Paris, France
Hôpital Saint-Antoine
Paris, France
Kyushyu University Hospital
Fukuoka, Japan
Hokkaido University Hospital
Sapporo, Japan
Hospital San Juan De Dios
Barcelona, Spain
King's College Hospital NHS Foundation Trust
London, United Kingdom
UCL Great Ormond Hospital
London, United Kingdom
The Christie NHS Foundation Trust
Manchester, United Kingdom